Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...
Clear structure, calm communication, and simple, predictable habits can make daily life far smoother for families, helping ...
In two newly published studies, researchers at the Department of Ethology, Eötvös Loránd University (Hungary) investigated ...
A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...
Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...
Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...
Evidence suggests that just 20 minutes of endurance exercise is sufficient to boost cognitive benefits in children with ADHD ...
Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...
Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...
Free Malaysia Today on MSN
Pfizer, Tris Pharma settle for $41.5 million in Texas ADHD drug case
Texas's top prosecutor on Wednesday announced the state had reached a $41.5 million settlement with US drugmakers Pfizer and ...
In October, Pharmac announced its decision to fund the Sandoz XR brand of methylphenidate. In December 2024, it began funding lisdexamfetamine to improve supply and provide more options for ADHD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback